 |
|
|
| |
Interactions Between ABT-493 plus ABT-530 combination and Rilpivirine or Raltegravir
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
*Rajneet K. Oberoi1, *Matthew P. Kosloski1, Bifeng Ding1, Beibei Hu1, Stanley Wang1, Jens Kort1, Sandeep Dutta1, Wei Liu1 *Contributed equally to the abstract 1AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
